Johnson & Johnson (JNJ) Revenue (2009 - 2026)

Johnson & Johnson's Revenue history runs 18 years deep, the most recent figure standing at $24.1 billion for Q1 2026.

• In Q1 2026, Revenue rose 9.91% year-over-year to $24.1 billion; the TTM figure through Mar 2026 stood at $96.4 billion (up 7.87% YoY), while the FY2025 annual figure was $94.2 billion, up 6.05% from the prior year.
• Revenue came in at $24.1 billion for Q1 2026 at Johnson & Johnson, down from $24.6 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $24.6 billion in Q4 2025 to a low of $19.8 billion in Q2 2022.
• A 5-year average of $21.9 billion and a median of $21.5 billion in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue dropped 14.32% in 2022 and advanced 9.91% in 2026, its largest moves.
• Johnson & Johnson's Revenue stood at $20.0 billion in 2022, then advanced by 7.0% to $21.4 billion in 2023, then increased by 5.26% to $22.5 billion in 2024, then increased by 9.08% to $24.6 billion in 2025, then slipped by 2.04% to $24.1 billion in 2026.
• According to Business Quant data, Revenue over the past three periods registered $24.1 billion, $24.6 billion, and $24.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison